MEDICAL RESEARCH AND YNHH
Yale professor explains high rates of metabolic disease in developing world

A Yale economics professor, Kaivan Munshi, uses the intersection of economics and biology to account for high rates of metabolic disease in the developing world. He found a threshold income rate at which metabolic disease prevalence rapidly increases.

Yale researchers develop digital tool to identify cases of elder abuse

A team of Yale researchers has developed a web-based app to empower and identify victims of elder abuse.

Yale study explores the effects of gendered racism on black girls

Researchers at Yale study the effects of gendered racism on black girls and propose possible solutions to mitigate these effects.

Yale experts make strides in Multiple Sclerosis research

Scientists at Yale School of Medicine have investigated the connection between inflammation and autoimmune diseases, particularly Multiple Sclerosis, and its impact on disease progression and quality of life.

Concerns and questions follow Yale New Haven Health System’s proposal to acquire three Conn. hospitals

Yale New Haven Health’s recent plan to acquire three new hospitals has sparked conversations and concerns over the impact of hospital consolidation on policy and economy.

Yale receives $10 million to study COVID-19 pathogenesis and its long-term effects

Yale researchers at the School of Medicine studying the pathogenic mechanisms and long-term effects of COVID-19 receive HHMI grant to further support their collaborative studies.

Yale researchers map gene regulation in tissue using novel sequencing technology

Yale researchers are the first to analyze gene regulation patterns in tissue after developing novel spatial epigenetics mapping technology.

Yale alumna becomes youngest female unicorn CEO

April Koh ’16 and Adam Checkroud GRD ’18 have created an entrepreneurial unicorn, or private company valued at above $1 billion, that aims to improve the delivery of mental healthcare services.

Yale and National Brain Tumor Society launch DNA Damage Response consortium

Yale professor Ranjit Bindra’s lab will launch the DNA Damage Response Consortium with the National Brain Tumor Society in order to further cutting-edge treatment for brain cancer.

A space for healers in need of healing

In a two-day writing workshop, resident physicians reflected on and derived meaning from the challenging world of medicine.

Yale study identifies potential target genes to develop therapeutic treatments for heart defect

A team of Yale researchers, led by Jui Dave and Daniel Greif, has identified potential therapeutic targets for combating the effects of supravalvular aortic stenosis.